跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Toprasenz - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Toprasenz
Approved
STANDARD
Toprasenz
Hanlim Pharm Co., Ltd
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
1385c97eab0afc86
Company
Hanlim Pharm Co., Ltd
Type
Standard
Approval Details
Approval Id
1385c97eab0afc86
Drug Approval Philippines Name
Toprasenz
Product Name
Toprasenz
Registration Number
DRP-6498-05
Brand Name
Toprasenz
Generic Name
Pantoprazole (As Sodium)
Dosage Form
Powder For Solution For Injection (IV)
Dosage Strength
40 mg
Manufacturer
Hanlim Pharm Co., Ltd
Importer
H & B Pharma International Inc
Distributor
Applied Pharmaceuticals Distribution Inc
Company Detail Path
/organization/hanlim-pharm-co-ltd
Issuance Date
27 April 2021
Expiry Date
20 April 2026
Pharmacologic Category
Proton Pump Inhibitor
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
1385c97eab0afc86
Type
Standard
Back to Philippines FDA Approvals